These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
381 related items for PubMed ID: 12748664
1. Allogeneic bone marrow transplantation for acute myeloblastic leukaemia in remission: risk factors for long-term morbidity and mortality. Robin M, Guardiola P, Dombret H, Baruchel A, Esperou H, Ribaud P, Devergie A, Gluckman E, Socié G. Bone Marrow Transplant; 2003 May; 31(10):877-87. PubMed ID: 12748664 [Abstract] [Full Text] [Related]
2. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine. Mehta J, Powles R, Treleaven J, Horton C, Tait D, Meller S, Pinkerton CR, Middleton G, Eisen T, Singhal S. Bone Marrow Transplant; 1996 Oct; 18(4):741-6. PubMed ID: 8899189 [Abstract] [Full Text] [Related]
3. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine. Mori T, Aisa Y, Watanabe R, Yamazaki R, Kato J, Shimizu T, Shigematsu N, Kubo A, Yajima T, Hibi T, Ikeda Y, Okamoto S. Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990 [Abstract] [Full Text] [Related]
4. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT). Frassoni F, Labopin M, Gluckman E, Prentice HG, Vernant JP, Zwaan F, Granena A, Gahrton G, De Witte T, Gratwohl A, Reiffers J, Gorin NC. Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048 [Abstract] [Full Text] [Related]
6. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation. De Witte T, Schattenberg A, Preijers F, Raymakers R, Muus P, Wessels J. Bone Marrow Transplant; 1993 Jan; 12 Suppl 3():S2-6. PubMed ID: 8124252 [Abstract] [Full Text] [Related]
7. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation. Gordon BG, Warkentin PI, Strandjord SE, Abromowitch M, Bayever E, Harper JL, Coccia PF. Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249 [Abstract] [Full Text] [Related]
8. Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission. Lee SH, Lee MH, Lee JH, Min YH, Lee KH, Cheong JW, Lee J, Park KW, Kang JH, Kim K, Kim WS, Jung CW, Choi SJ, Lee JH, Park K. Biol Blood Marrow Transplant; 2005 Feb; 11(2):122-8. PubMed ID: 15682073 [Abstract] [Full Text] [Related]
9. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation. Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, Chen YH, Zhang XH, Lu DP. Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686 [Abstract] [Full Text] [Related]
10. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival. Valcárcel D, Martino R, Caballero D, Martin J, Ferra C, Nieto JB, Sampol A, Bernal MT, Piñana JL, Vazquez L, Ribera JM, Besalduch J, Moraleda JM, Carrera D, Brunet MS, Perez-Simón JA, Sierra J. J Clin Oncol; 2008 Feb 01; 26(4):577-84. PubMed ID: 18086801 [Abstract] [Full Text] [Related]
11. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran. Zakerinia M, Khojasteh HN, Ramzi M, Haghshenas M. Transplant Proc; 2005 Dec 01; 37(10):4477-81. PubMed ID: 16387149 [Abstract] [Full Text] [Related]
12. Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow. Garderet L, Labopin M, Gorin NC, Polge E, Fouillard L, Ehninger GE, Ringden O, Finke J, Tura S, Frassoni F. Bone Marrow Transplant; 2003 Jan 01; 31(1):23-9. PubMed ID: 12621503 [Abstract] [Full Text] [Related]
13. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group. Jacobsen N, Badsberg JH, Lönnqvist B, Ringdén O, Volin L, Rajantie J, Nikoskelainen J, Keiding N. Bone Marrow Transplant; 1990 Jun 01; 5(6):413-8. PubMed ID: 2164434 [Abstract] [Full Text] [Related]
14. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up. Oyekunle AA, Kröger N, Zabelina T, Ayuk F, Schieder H, Renges H, Fehse N, Waschke O, Fehse B, Kabisch H, Zander AR. Bone Marrow Transplant; 2006 Jan 01; 37(1):45-50. PubMed ID: 16258531 [Abstract] [Full Text] [Related]
15. Is there a role for autologous stem cell transplantation for patients with acute myelogenous leukemia? A retrospective analysis. Novitzky N, Thomas V, du Toit C, McDonald A. Biol Blood Marrow Transplant; 2011 Jun 01; 17(6):875-84. PubMed ID: 20870030 [Abstract] [Full Text] [Related]
16. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy. Ortega JJ, Díaz de Heredia C, Olivé T, Bastida P, Llort A, Armadans L, Torrabadella M, Massuet L. Haematologica; 2003 Mar 01; 88(3):290-9. PubMed ID: 12651268 [Abstract] [Full Text] [Related]
17. Improved outcome in young adults with de novo acute myeloid leukemia in first remission, undergoing an allogeneic bone marrow transplant. Vicente D, Lamparelli T, Gualandi F, Occhini D, Raiola AM, Ibatici A, Van Lint MT, Gobbi M, Miglino M, Clavio M, Risso M, Frassoni F, Bacigalupo A. Bone Marrow Transplant; 2007 Aug 01; 40(4):349-54. PubMed ID: 17589537 [Abstract] [Full Text] [Related]
18. The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapy. Cook G, Clark RE, Crawley C, Mackinnon S, Russell N, Thomson K, Pearce RM, Towlson K, Marks DI. Biol Blood Marrow Transplant; 2006 Mar 01; 12(3):293-300. PubMed ID: 16503498 [Abstract] [Full Text] [Related]
19. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation. Meisel R, Enczmann J, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Wernet P, Göbel U, Laws HJ, Dilloo D. Klin Padiatr; 2005 Mar 01; 217(3):135-41. PubMed ID: 15858704 [Abstract] [Full Text] [Related]
20. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants. Al-Kasim FA, Thornley I, Rolland M, Lau W, Tsang R, Freedman MH, Saunders EF, Calderwood S, Doyle JJ. Br J Haematol; 2002 Feb 01; 116(2):483-90. PubMed ID: 11841456 [Abstract] [Full Text] [Related] Page: [Next] [New Search]